P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs

Molecular Cancer Therapeutics

Volumn 1, Issue 3, 2002, Pages 205-213

  Shabbits, Jennifer A ^a   Mayer, Lawrence D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 DECANOYLAMINO 3 MORPHOLINO 1 PHENYL 1 PROPANOL; ANTINEOPLASTIC AGENT; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE; ENZYME INHIBITOR; GLUCOSYLTRANSFERASE; GLYCOPROTEIN P; MORPHOLINE DERIVATIVE; PACLITAXEL; PALMITIC ACID; TUBULIN; VINCRISTINE;

ARTICLE; BREAST TUMOR; CELL CULTURE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG RESISTANCE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENETICS; HUMAN; METABOLISM; MULTIDRUG RESISTANCE; PATHOLOGY; PROTEIN TRANSPORT;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL SURVIVAL; CERAMIDES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; FLOW CYTOMETRY; GLUCOSYLTRANSFERASES; HUMANS; MICROSCOPY, FLUORESCENCE; MORPHOLINES; P-GLYCOPROTEIN; PACLITAXEL; PALMITIC ACID; PROTEIN TRANSPORT; TUBULIN; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 0036045129     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. van Helvoort, A., Smith, A. J., Sprong, H., Fritzsche, I., Schinkel, A. H., Borst, P., and van Meer, G. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell, 87: 507-517, 1996. (Pubitemid 26374324)
2. van Helvoort, A., Giudici, M. L., Thielemans, M., and van Meer, G. Transport of sphingomyelin to the cell surface is inhibited by brefeldin A and in mitosis, where C6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity. J. Cell Sci., 110: 75-83, 1997. (Pubitemid 27057946)
3. Smyth, M. J., Krasovskis, E., Sutton, V. R., and Johnstone, R. W. The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc. Natl. Acad. Sci. USA, 95: 7024-7029, 1998.
4. Hannun, Y. A. Functions of ceramide in coordinating cellular responses to stress. Science (Wash. DC), 274: 1855-1859, 1996. (Pubitemid 26424756)
5. Tepper, C. G., Jayadev, S., Liu, B., Bielawska, A., Wolff, R., Yonehara, S., Hannun, Y. A., and Seldin, M. F. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA, 92: 8443-8447, 1995.
6. Cifone, M. G., De Maria, R., Roncaioli, P., Rippo, M. R., Azuma, M., Lanier, L. L., Santoni, A., and Testi, R. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med., 180: 1547-1552, 1994. (Pubitemid 24289629)
7. Haimovitz-Friedman, A., Kan, C. C., Ehleiter, D., Persaud, R. S., McLoughlin, M., Fuks, Z., and Kolesnick, R. N. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med., 180: 525-535, 1994. (Pubitemid 24224129)
8. Zhang, Y., Mattjus, P., Schmid, P. C., Dong, Z., Zhong, S., Ma, W. Y., Brown, R. E., Bode, A. M., and Schmid, H. H. Involvement of the acid sphingomyelinase pathway in uva-induced apoptosis. J. Biol. Chem., 276: 11775-11782, 2001.
9. Jarvis, W. D., and Grant, S. The role of ceramide in the cellular response to cytotoxic agents. Curr. Opin. Oncol., 10: 552-559, 1998. (Pubitemid 28502250)
10. Zhang, J., Alter, N., Reed, J. C., Borner, C., Obeid, L. M., and Hannun, Y. A. Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc. Natl. Acad. Sci. USA, 93: 5325-5328, 1996. (Pubitemid 26159448)
11. Jaffrezou, J. P., Levade, T., Bettaieb, A., Andrieu, N., Bezombes, C., Maestre, N., Vermeersch, S., Rousse, A., and Laurent, G. Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J., 15: 2417-2424, 1996. (Pubitemid 26151181)
12. Perry, D. K., Carton, J., Shah, A. K., Meredith, F., Uhlinger, D. J., and Hannun, Y. A. Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J. Biol. Chem., 275: 9078-9084, 2000. (Pubitemid 30180269)
13. Veldman, R. J., Sietsma, H., Klappe, K., Hoekstra, D., and Kok, J. W. Inhibition of P-glycoprotein activity and chemosensitization of multidrug-resistant ovarian carcinoma 2780AD cells by hexanoylglucosylceramide. Biochem. Biophys. Res. Commun., 266: 492-496, 1999. (Pubitemid 30028695)
14. Lucci, A., Cho, W. I., Han, T. Y., Giuliano, A. E., Morton, D. L., and Cabot, M. C. Glucosylceramide: a marker for multiple-drug resistant cancers. Anticancer Res., 18: 475-480, 1998. (Pubitemid 28174859)
15. Liu, Y. Y., Han, T. Y., Giuliano, A. E., and Cabot, M. C. Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J., 15: 719-730, 2001. (Pubitemid 32245990)
16. Radin, N. S., Shayman, J. A., and Inokuchi, J. Metabolic effects of inhibiting glucosylceramide synthesis with PDMP and other substances. Adv. Lipid Res., 26: 183-213, 1993.
17. Sietsma, H., Veldman, R. J., Kolk, D., Ausema, B., Nijhof, W., Kamps, W., Vellenga, E., and Kok, J. W. 1-Phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for Taxol and vincristine. Clin. Cancer Res., 6: 942-948, 2000. (Pubitemid 30159352)
18. Dragowska, W. H., Lopes de Menezes, D. E., Sartor, J., and Mayer, L. D. Quantitative fluorescence cytometric analysis of Bcl-2 levels in tumor cells exhibiting a wide range of inherent Bcl-2 protein expression: correlation with Western blot analysis. Cytometry, 40: 346-352, 2000. (Pubitemid 30643193)
19. Li, R., Blanchette-Mackie, E. J., and Ladisch, S. Induction of endocytic vesicles by exogenous C6-ceramide. J. Biol. Chem., 274: 21121-21127, 1999.
20. Lucci, A., Giuliano, A. E., Han, T. Y., Dinur, T., Liu, Y. Y., Senchenkov, A., and Cabot, M. C. Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells. Int. J. Oncol., 15: 535-540, 1999.
21. Lavie, Y., Cao, H., Bursten, S. L., Giuliano, A. E., and Cabot, M. C. Accumulation of glucosylceramides in multidrug-resistant cancer cells. J. Biol. Chem., 271: 19530-19536, 1996. (Pubitemid 26271630)
22. Lucci, A., Han, T. Y., Liu, Y. Y., Giuliano, A. E., and Cabot, M. C. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells. Cancer (Phila.), 86: 300-311, 1999. (Pubitemid 29327587)
23. Cai, Z., Bettaieb, A., Mahdani, N. E., Legres, L. G., Stancou, R., Masliah, J., and Chouaib, S. Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-α-mediated cytotoxicity. J. Biol. Chem., 272: 6918-6926, 1997. (Pubitemid 27166390)
24. Liu, Y. Y., Han, T. Y., Giuliano, A. E., and Cabot, M. C. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers Adriamycin resistance in human breast cancer cells. J. Biol. Chem., 274: 1140-1146, 1999.
25. Charles, A. G., Han, T. Y., Liu, Y. Y., Hansen, N., Giuliano, A. E., and Cabot, M. C. Taxol-induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemother. Pharmacol., 47: 444-450, 2001. (Pubitemid 32397622)
26. Lavie, Y., Cao, H., Volner, A., Lucci, A., Han, T. Y., Geffen, V., Giuliano, A. E., and Cabot, M. C. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J. Biol. Chem., 272: 1682-1687, 1997. (Pubitemid 27043253)
27. Jeckel, D., Karrenbauer, A., Burger, K. N., van Meer, G., and Wieland, F. Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions. J. Cell Biol., 117: 259-267, 1992.
28. Trinchera, M., Fabbri, M., and Ghidoni, R. Topography of glycosyltransferases involved in the initial glycosylations of gangliosides. J. Biol. Chem., 266: 20907-20912, 1991. (Pubitemid 21908550)
29. Molinari, A., Calcabrini, A., Meschini, S., Stringaro, A., Del Bufalo, D., Cianfriglia, M., and Arancia, G. Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells. Int. J. Cancer, 75: 885-893, 1998. (Pubitemid 28134114)
30. Molinari, A., Cianfriglia, M., Meschini, S., Calcabrini, A., and Arancia, G. P-glycoprotein expression in the Golgi apparatus of multidrug-resistant cells. Int. J. Cancer, 59: 789-795, 1994.
31. Bour-Dill, C., Gramain, M. P., Merlin, J. L., Marchal, S., and Guillemin, F. Determination of intracellular organelles implicated in daunorubicin cytoplasmic sequestration in multidrug-resistant MCF-7 cells using fluorescence microscopy image analysis. Cytometry, 39: 16-25, 2000. (Pubitemid 30043226)
32. Shapiro, A. B., Fox, K., Lee, P., Yang, Y. D., and Ling, V. Functional intracellular P-glycoprotein. Int. J. Cancer, 76: 857-864, 1998. (Pubitemid 28262105)
33. Labroille, G., Belloc, F., Bilhou-Nabera, C., Bonnefille, S., Bascans, E., Boisseau, M. R., Bernard, P., and Lacombe, F. Cytometric study of intracellular P-gp expression and reversal of drug resistance. Cytometry, 32: 86-94, 1998. (Pubitemid 28246755)
34. Lannert, H., Bunning, C., Jeckel, D., and Wieland, F. T. Lactosylceramide is synthesized in the lumen of the Golgi apparatus. FEBS Lett., 342: 91-96, 1994. (Pubitemid 24101400)
35. Lannert, H., Gorgas, K., Meissner, I., Wieland, F. T., and Jeckel, D. Functional organization of the Golgi apparatus in glycosphingolipid biosynthesis. Lactosylceramide and subsequent glycosphingolipids are formed in the lumen of the late Golgi. J. Biol. Chem., 273: 2939-2946, 1998.
36. van Echten, G., and Sandhoff, K. Ganglioside metabolism. Enzymology, topology, and regulation. J. Biol. Chem., 268: 5341-5344, 1993.